What are the latest clinical trials for Lung Cancer in 2026

Latest Clinical Trials for Lung Cancer in 2026

I appreciate your question about current clinical trials. However, I need to be transparent about an important limitation: my knowledge was last updated in November 2025, so I don't have access to trials that may have been initiated or updated after that date.

That said, I can share what the most recent guidelines tell us about the direction of lung cancer research and the types of trials that are actively enrolling or launching.

Current Research Directions (Based on Latest Guidelines)

According to the NCCN Guidelines for Non-Small Cell Lung Cancer (Version 8.2025), the field is actively pursuing several key areas:

1. Targeted Therapy Advances

• EGFR mutations: Trials continue testing newer-generation EGFR inhibitors and combination approaches (like amivantamab plus lazertinib)
• ALK rearrangements: Studies of next-generation ALK inhibitors for patients who develop resistance
• KRAS G12C mutations: Expanding use of sotorasib and adagrasib with combination therapies
• ROS1 and RET fusions: Newer TRK inhibitors and multi-targeted approaches

2. Immunotherapy Combinations

The NCCN Guidelines highlight ongoing research combining:

• Checkpoint inhibitors (pembrolizumab, nivolumab, atezolizumab, durvalumab)
• Chemotherapy plus immunotherapy
• Dual immunotherapy approaches (nivolumab + ipilimumab)

3. Early Detection & Prevention

According to the guidelines, there's significant focus on:

• Blood-based biomarker testing (cell-free DNA/cfDNA) for early detection
• Liquid biopsy for monitoring treatment response and detecting resistance

How to Find Current 2026 Trials

For the most up-to-date information on trials actively enrolling in 2026, I recommend:

✅ ClinicalTrials.gov (www.clinicaltrials.gov)

• Search: "lung cancer" + your specific type (NSCLC, SCLC, etc.)
• Filter by: Status (Recruiting/Enrolling), Location, and Phase

✅ NCCN Clinical Trial Finder (www.nccn.org/clinical-trials)

• Specifically curated trials aligned with NCCN Guidelines

✅ Cancer.gov (National Cancer Institute)

• NCI-supported trials with detailed information

✅ Your Oncology Team

• They can identify trials matching YOUR specific diagnosis, stage, and biomarkers

Questions to Ask Your Doctor About Trials

If you're interested in clinical trial participation, consider asking:

1. "Are there any trials available for my specific lung cancer type and biomarker status?"
2. "What are the eligibility requirements, and do I qualify?"
3. "What are the potential benefits and risks compared to standard treatment?"
4. "How often would I need to visit the trial site, and what tests are involved?"
5. "What happens to my care if I need to stop the trial?"

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.